InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（0 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
0
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
无可用的信号评分。
Browse the complete record of transactions filed by Rosol Michael Stanley, Directeur Médical. Insider active across 1 company, notably Navidea Biopharmaceuticals, INC.. Aggregated, 2 filings have been published. Activity tracked since 14 January 2022. The latest transaction was disclosed on 9 September 2022 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Rosol Michael Stanley
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报2 总计
28,150 股0Common StockSEC:0001437749-22-022307:0
7,728 股0Common StockSEC:0001437749-22-001026:0
2 条申报中的 2 条
About Rosol Michael Stanley
Rosol Michael Stanley is the Chief Medical Officer at NAVIDEA BIOPHARMACEUTICALS, INC. He oversees the company's medical and research initiatives, ensuring that projects meet the highest standards. His expertise is crucial for the development of new therapies.
